• ABOUT
  • UNBUZZD™
  • LUCID-MS
  • INVESTORS
  • TEAM
  • NEWS & EVENTS
  • QUANTUM VS BANKS
  • CONTACT
NASDAQ:QNTM
CSE:QNTM | FRA:0K91
Logo of Quantum Biopharma. Click to go to a Home page
NASDAQ:QNTM | CSE:QNTM | FRA:0K91
Logo of Quantum Biopharma. Click to go to a Home page
  • ABOUT
  • UNBUZZD™
  • LUCID-MS
  • Investors
  • TEAM
  • NEWS & EVENTS
  • QUANTUM VS BANKS
  • CONTACT

Corporate Governance

☰  IR MENU
  • Investors
  • Events
  • Press Releases
  • Financials & Filings
    • SEC Filings
    • Financial Results
    • Annual Reports
    • SEDAR+
    • Annual General Meeting Materials
  • Stock Info
  • Governance
  • Investor FAQ
  • Email Alerts
  • Investors
  • Events
  • Press Releases
  • Financials & Filings
    • SEC Filings
    • Financial Results
    • Annual Reports
    • SEDAR+
    • Annual General Meeting Materials
  • Stock Info
  • Governance
  • Investor FAQ
  • Email Alerts

Code of Conduct and Ethics

Download PDF

Nasdaq Corporate Governance Disclosure Statement

Download PDF

Board Diversity Matrix 2024

Download PDF

Board Diversity Matrix 2023

Download PDF

Board Diversity Matrix 2022

View Matrix
A blue and white dna molecule on a white background.

© Copyright 2025 Quantum BioPharma. All Rights Reserved. Powered by ACCESS Newswire.

Investor Relations

Chris Tyson
Executive Vice President
MZ North America
Direct: 949-491-8235
QNTM@mzgroup.us 

General Inquiries

www.quantumbiopharma.com/contact

info@quantumbiopharma.com

+1-833-571-1811

Headquarters

55 University Ave. , Suite 1003
Toronto, ON, M5J 2H7 Canada

Registered Office Address

Corporation Trust Centre
1209 Orange Street

Wilmington, Delaware, 19801, USA

Email Alerts

Sign Up Today
Share by: